{"transactions":[{"id":4622912,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-18T20:25:40.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date."}],"balance_after":10000,"derivative":{"exercise_price":95.22,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001612627-26-000007","document":"wk-form4a_1789763137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000161262726000007/wk-form4a_1789763137.xml","form_type":"4/A","original_submission_date":"2026-06-04"}},{"id":749148,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T21:29:14.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date."}],"balance_after":15000,"derivative":{"exercise_price":95.22,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001612627-26-000004","document":"wk-form4_1780608551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000161262726000004/wk-form4_1780608551.xml","form_type":"4"}},{"id":778236,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-15T21:24:57.000Z","date":"2026-05-15","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":12.18,"expiration_date":"2031-03-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-26-021726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036126021726/form4.xml","form_type":"4"}},{"id":778235,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-15T21:24:57.000Z","date":"2026-05-15","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":6.81,"expiration_date":"2032-03-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-26-021726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036126021726/form4.xml","form_type":"4"}},{"id":778234,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-15T21:24:57.000Z","date":"2026-05-15","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":3.14,"expiration_date":"2033-03-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-26-021726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036126021726/form4.xml","form_type":"4"}},{"id":778233,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-15T21:24:57.000Z","date":"2026-05-15","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":3.2,"expiration_date":"2034-03-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-26-021726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036126021726/form4.xml","form_type":"4"}},{"id":778232,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-15T21:24:57.000Z","date":"2026-05-15","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 15, 2026, pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each vested stock option that had an exercise price per Share that was less than the Offer Price and that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding taxes), equal to the product of: (i) the total number of Shares subject to such option, multiplied by (ii) the excess, if any, of (A) the Offer Price over (B) the exercise price payable per Share under such option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 15, 2026, pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each vested stock option that had an exercise price per Share that was less than the Offer Price and that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding taxes), equal to the product of: (i) the total number of Shares subject to such option, multiplied by (ii) the excess, if any, of (A) the Offer Price over (B) the exercise price payable per Share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each stock option that was either (i) unvested or (ii) that had a per share exercise price per Share that was equal to or more than the Offer Price that was then outstanding and unexercised as of immediately prior to the Effective Time was cancelled without any consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":2.06,"expiration_date":"2035-03-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-26-021726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036126021726/form4.xml","form_type":"4"}},{"id":778231,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-15T21:24:57.000Z","date":"2026-05-15","kind":"other","planned":false,"acquired":false,"shares":28757,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated April 2, 2026, by and between Forian Inc., a Maryland corporation (the \"Issuer\"), 2025 Acquisition Company, LLC, a Delaware limited liability company (\"Parent\"), and Bravo Merger Sub, Inc., a Maryland corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), on May 15, 2026, Parent and Merger Sub completed a tender offer for the shares of the Issuer's common stock (the \"Shares\"). In exchange for each Share, tendering shareholders received $2.17 per Share (the \"Offer Price\"), payable in cash, without interest and subject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-26-021726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036126021726/form4.xml","form_type":"4"}},{"id":778877,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T22:15:40.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":9149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":9149,"derivative":{"exercise_price":1.19,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":9149},"source":{"system":"sec-edgar","filing":"0001612627-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000161262726000002/ownership.xml","form_type":"4"}},{"id":1113192,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:50:58.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option\nholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000069","document":"wk-form4_1749761452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000069/wk-form4_1749761452.xml","form_type":"4"}},{"id":1130219,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-29T20:32:20.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will be fully exercisable on May 28, 2026, subject to the reporting person's continued service through such date."}],"balance_after":15000,"derivative":{"exercise_price":12.91,"exercise_date":"2026-05-28","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0002007919-25-000070","document":"wk-form4_1748550731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000200791925000070/wk-form4_1748550731.xml","form_type":"4"}},{"id":1189226,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-03-28T22:55:53.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments beginning on March 26, 2026, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date"}],"balance_after":15000,"derivative":{"exercise_price":2.06,"expiration_date":"2035-03-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-25-011045","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036125011045/form4.xml","form_type":"4"}},{"id":1389917,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-07T20:34:17.000Z","date":"2024-10-03","kind":"purchase","planned":false,"acquired":true,"shares":6667,"price":15,"value":100005.0,"ownership":{"direct":true},"balance_after":20443,"source":{"system":"sec-edgar","filing":"0002007919-24-000051","document":"wk-form4_1728333250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000200791924000051/wk-form4_1728333250.xml","form_type":"4"}},{"id":1408337,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-12T21:14:23.000Z","date":"2024-09-11","kind":"purchase","planned":false,"acquired":true,"shares":6457,"price":15.07,"value":97306.99,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":13776,"source":{"system":"sec-edgar","filing":"0002007919-24-000047","document":"wk-form4_1726175657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000200791924000047/wk-form4_1726175657.xml","form_type":"4"}},{"id":1408336,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-12T21:14:23.000Z","date":"2024-09-10","kind":"purchase","planned":false,"acquired":true,"shares":179,"price":15,"value":2685.0,"ownership":{"direct":true},"balance_after":7319,"source":{"system":"sec-edgar","filing":"0002007919-24-000047","document":"wk-form4_1726175657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000200791924000047/wk-form4_1726175657.xml","form_type":"4"}},{"id":1417432,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-03T20:27:44.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":7140,"price":14,"value":99960.0,"ownership":{"direct":true},"balance_after":7140,"source":{"system":"sec-edgar","filing":"0001739614-24-000035","document":"wk-form4_1725395257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000173961424000035/wk-form4_1725395257.xml","form_type":"4"}},{"id":1473029,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:23:04.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000035","document":"wk-form4_1718914977.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000035/wk-form4_1718914977.xml","form_type":"4"}},{"id":1497471,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:23:36.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This stock option was canceled in the Merger without any consideration being payable in respect thereof, and has no further force or effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on December 7, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":40.45,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950142-24-001502","document":"es240484814_4-vuori.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000095014224001502/es240484814_4-vuori.xml","form_type":"4"}},{"id":1497470,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:23:36.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock option immediately prior to the effective time, multiplied by (y) the excess of (I) an amount in cash equal to $30.00, without interest thereon over (II) the exercise price payable per share of the Issuer common stock under such option and (B) one (1) contractual contingent value right for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on May 25, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":12.57,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950142-24-001502","document":"es240484814_4-vuori.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000095014224001502/es240484814_4-vuori.xml","form_type":"4"}},{"id":1497469,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:23:36.000Z","date":"2024-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated January 22, 2024 (the \"Merger Agreement\"), by and among Inhibrx, Inc. (the \"Issuer\"), Aventis Inc., a Pennsylvania corporation (\"Parent\") and wholly owned subsidiary of Sanofi, and Art Acquisition Sub, Inc., a Delaware corporation (\"Merger Sub\") and wholly owned subsidiary of Parent, following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on May 30, 2024, Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This stock option was cancelled in the Merger and converted into the right to receive (A) an amount in cash, without interest and less any applicable withholding taxes, equal to the product of (x) the total number of shares of the Issuer's common stock subject to such stock option immediately prior to the effective time, multiplied by (y) the excess of (I) an amount in cash equal to $30.00, without interest thereon over (II) the exercise price payable per share of the Issuer common stock under such option and (B) one (1) contractual contingent value right for each share of the Issuer common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on May 25, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":0,"derivative":{"exercise_price":23.03,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950142-24-001502","document":"es240484814_4-vuori.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000095014224001502/es240484814_4-vuori.xml","form_type":"4"}},{"id":1497468,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T22:11:30.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This stock option was granted following the consummation of the merger of Inhibrx, Inc. with a wholly owned indirect subsidiary of Sanofi."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will be fully exercisable on May 30, 2025, subject to the reporting person's continued service through such date."}],"balance_after":30000,"derivative":{"exercise_price":15.86,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950142-24-001495","document":"es240484865_4-vuori.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000095014224001495/es240484865_4-vuori.xml","form_type":"4"}},{"id":1558948,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-03-28T23:44:47.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments beginning on March 27, 2025, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":3.2,"expiration_date":"2034-03-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-24-016324","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036124016324/form4.xml","form_type":"4"}},{"id":1851919,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:15:02.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000053","document":"wf-form4_168694648962541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000053/wf-form4_168694648962541.xml","form_type":"4"}},{"id":1874231,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T20:10:43.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":15000,"derivative":{"exercise_price":23.03,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001739614-23-000054","document":"wk-form4_1685477428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000173961423000054/wk-form4_1685477428.xml","form_type":"4"}},{"id":1939723,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-03-24T22:50:20.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments beginning on March 23, 2024, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":3.14,"expiration_date":"2033-03-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-23-013814","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036123013814/form4.xml","form_type":"4"}},{"id":2206262,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-18T23:26:55.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":44470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029."}],"balance_after":44470,"derivative":{"exercise_price":0.51,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":44470},"source":{"system":"sec-edgar","filing":"0001209191-22-042482","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122042482/doc4a.xml","form_type":"4/A","original_submission_date":"2020-07-02"}},{"id":2233983,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:27:36.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":164422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":164422,"derivative":{"exercise_price":1.62,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":164422},"source":{"system":"sec-edgar","filing":"0001209191-22-036316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919122036316/doc4.xml","form_type":"4"}},{"id":2254881,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-26T20:34:15.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":45000,"derivative":{"exercise_price":12.57,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001739614-22-000063","document":"wf-form4_165359722506010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000173961422000063/wf-form4_165359722506010.xml","form_type":"4"}},{"id":2295982,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-04-18T23:56:50.000Z","date":"2022-03-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments beginning on March 17, 2023, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":6.81,"expiration_date":"2032-03-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-22-014926","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036122014926/form4.xml","form_type":"4"}},{"id":2481700,"issuer":{"id":90351,"kind":"organization","name":"Inhibrx, Inc.","symbol":"INBX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T00:43:02.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on December 7, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter."}],"balance_after":30000,"derivative":{"exercise_price":40.45,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001739614-21-000117","document":"wf-form4_163892416605245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000173961421000117/wf-form4_163892416605245.xml","form_type":"4"}},{"id":2596042,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-19T21:47:01.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":40751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":40751,"derivative":{"exercise_price":5.34,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":40751},"source":{"system":"sec-edgar","filing":"0001209191-21-052600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121052600/doc4.xml","form_type":"4"}},{"id":2669982,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T23:10:50.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":7528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":7528,"derivative":{"exercise_price":7.64,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":7528},"source":{"system":"sec-edgar","filing":"0001209191-21-040389","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919121040389/doc4.xml","form_type":"4"}},{"id":2744687,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T20:59:14.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of this option will vest on April 15, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of common stock. All shares of common stock underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan."}],"balance_after":42000,"derivative":{"exercise_price":2.47,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001636050-21-000051","document":"wf-form4_161886593930821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000163605021000051/wf-form4_161886593930821.xml","form_type":"4"}},{"id":2801736,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-03-09T22:19:55.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in four equal annual installments beginning on March 2, 2022, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":12.18,"expiration_date":"2031-03-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-21-007805","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036121007805/form4.xml","form_type":"4"}},{"id":2801735,"issuer":{"id":47119,"kind":"organization","name":"Forian Inc.","symbol":"FORA"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-03-09T22:19:55.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 5,000 restricted stock units which vest in four equal annual installments beginning on March 2, 2022, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-21-007805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036121007805/form4.xml","form_type":"4"}},{"id":3010590,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-08T01:28:25.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common shares underlying this option vest over a period of three years, with one-third of the common shares vesting on each of the first, second and third anniversaries of October 5, 2020, the date of the Reporting Person's appointment to the Issuer's Board of Directors. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."}],"balance_after":35000,"derivative":{"exercise_price":5.63,"expiration_date":"2030-10-04","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-054255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612627/000120919120054255/doc4.xml","form_type":"4"}},{"id":3091485,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-03T00:37:03.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":44470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."}],"balance_after":44470,"derivative":{"exercise_price":0.51,"expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":44470},"source":{"system":"sec-edgar","filing":"0001209191-20-040769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919120040769/doc4.xml","form_type":"4"}},{"id":3495619,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-10T21:31:31.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":30274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a three year period such that the option is fully vested on June 6, 2022, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."}],"balance_after":30274,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":30274},"source":{"system":"sec-edgar","filing":"0001209191-19-035894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919119035894/doc4.xml","form_type":"4"}},{"id":4208110,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-15T12:12:48.000Z","date":"2017-09-15","kind":"disposition_to_issuer","acquired":false,"shares":13200,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."}],"balance_after":0,"derivative":{"exercise_price":49.57,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0000947871-17-000724","document":"ss59052_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787117000724/ss59052_4.xml","form_type":"4"}},{"id":4208109,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-15T12:12:48.000Z","date":"2017-09-15","kind":"disposition_to_issuer","acquired":false,"shares":13200,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."}],"balance_after":0,"derivative":{"exercise_price":48.3,"expiration_date":"2026-01-01","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0000947871-17-000724","document":"ss59052_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787117000724/ss59052_4.xml","form_type":"4"}},{"id":4208108,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-15T12:12:48.000Z","date":"2017-09-15","kind":"disposition_to_issuer","acquired":false,"shares":13200,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."}],"balance_after":0,"derivative":{"exercise_price":39.55,"expiration_date":"2025-01-01","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0000947871-17-000724","document":"ss59052_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787117000724/ss59052_4.xml","form_type":"4"}},{"id":4208107,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-15T12:12:48.000Z","date":"2017-09-15","kind":"disposition_to_issuer","acquired":false,"shares":13200,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 15, 2017, the merger transaction (the \"Merger\") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD."}],"balance_after":0,"derivative":{"exercise_price":50.89,"expiration_date":"2024-07-07","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0000947871-17-000724","document":"ss59052_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787117000724/ss59052_4.xml","form_type":"4"}},{"id":4208106,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-15T12:12:48.000Z","date":"2017-09-15","kind":"other","acquired":false,"shares":1790,"price":66.5,"value":119035.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation (\"Purchaser\") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company (\"Parent\"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation (\"WebMD\"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the \"Merger Agreement\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000947871-17-000724","document":"ss59052_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787117000724/ss59052_4.xml","form_type":"4"}},{"id":4507308,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-03T16:49:35.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":13200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option are scheduled to vest on each of the first, second, third and fourth anniversary of the date of the grant (fully vested on the 4th anniversary of the grant date)."}],"balance_after":13200,"derivative":{"exercise_price":49.57,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0000947871-17-000010","document":"ss25389_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787117000010/ss25389_4.xml","form_type":"4"}},{"id":4523511,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-13T13:17:26.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":400,"price":53.02,"value":21208.0,"ownership":{"direct":true},"balance_after":1790,"source":{"system":"sec-edgar","filing":"0000947871-16-001767","document":"ss23257_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787116001767/ss23257_4.xml","form_type":"4"}},{"id":4523510,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-13T13:17:26.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":1161,"price":53.01,"value":61544.61,"ownership":{"direct":true},"balance_after":2190,"source":{"system":"sec-edgar","filing":"0000947871-16-001767","document":"ss23257_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787116001767/ss23257_4.xml","form_type":"4"}},{"id":4550038,"issuer":{"id":12671,"kind":"organization","name":"WebMD Health Corp.","symbol":"WBMD"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T18:17:56.000Z","date":"2016-11-15","kind":"grant","acquired":true,"shares":928,"price":53.83,"value":49954.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Payment of annual retainer for services as a non-employee member of the Board of Directors and its committees."}],"balance_after":3351,"source":{"system":"sec-edgar","filing":"0000947871-16-001698","document":"ss19903_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326583/000094787116001698/ss19903_4.xml","form_type":"4"}}]}